|
MCM4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.811000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.724200E-02 |
| Normal-vs-Stage2 |
7.284600E-01 |
| Normal-vs-Stage3 |
7.589900E-02 |
| Normal-vs-Stage4 |
7.677600E-01 |
| Stage1-vs-Stage2 |
4.496000E-01 |
| Stage1-vs-Stage3 |
8.239700E-03 |
| Stage1-vs-Stage4 |
5.403400E-01 |
| Stage2-vs-Stage3 |
1.141420E-01 |
| Stage2-vs-Stage4 |
9.775200E-01 |
| Stage3-vs-Stage4 |
2.066400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.819600E-01 |
| Normal-vs-AfricanAmerican |
2.909800E-01 |
| Normal-vs-Asian |
3.828200E-01 |
| Caucasian-vs-AfricanAmerican |
8.526800E-01 |
| Caucasian-vs-Asian |
8.719200E-01 |
| AfricanAmerican-vs-Asian |
9.064800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.159300E-03 |
| Normal-vs-Female |
2.193900E-02 |
| Male-vs-Female |
1.552520E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.113600E-01 |
| Normal-vs-Extreme_Weight |
5.174400E-04 |
| Normal-vs-Obese |
3.202600E-01 |
| Normal-vs-Extreme_Obese |
2.517400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.062000E-01 |
| Normal_Weight-vs-Obese |
8.786400E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.592000E-01 |
| Extreme_Weight-vs-Obese |
4.719900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.880600E-01 |
| Obese-vs-Extreme_Obese |
1.114610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.192610E-01 |
| Normal-vs-Age(41-60Yrs) |
3.854200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.499900E-02 |
| Normal-vs-Age(81-100Yrs) |
2.362000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.694400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.991500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.687600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.492800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.747800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.840000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.240500E-04 |
| Normal-VS-Type2 PRCC |
6.992000E-01 |
| Normal-VS-KIRP CIMP |
2.461700E-02 |
| Normal-VS-Unclassified PRCC |
9.806600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.322120E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.173940E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.796250E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.252400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.628000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.613800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.367400E-01 |
| Normal-vs-N1 |
5.018500E-02 |
| Normal-vs-N2 |
6.368400E-01 |
| N0-vs-N1 |
2.114100E-02 |
| N0-vs-N2 |
3.448200E-01 |
| N1-vs-N2 |
6.252600E-01 |
|
|
